胆石症(Cholelithiasis):世界の治験レビュー(2015年上半期版)

◆英語タイトル:Cholelithiasis Global Clinical Trials Review, H1, 2015
◆商品コード:GDHC2534CTIDB
◆発行会社(リサーチ会社):GlobalData
◆発行日:2015年1月21日
◆ページ数:61
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥540,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥810,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

当調査レポートでは、世界における胆石症(Cholelithiasis) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - 胆石症(Cholelithiasis)
  - 当レポートの概要
・胆石症(Cholelithiasis):各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
【レポートの概要】

Cholelithiasis Global Clinical Trials Review, H1, 2015

Summary

GlobalData’s clinical trial report, “Cholelithiasis Global Clinical Trials Review, H1, 2015″ provides data on the Cholelithiasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cholelithiasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cholelithiasis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Cholelithiasis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Cholelithiasis to Gastrointestinal Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Cholelithiasis to Gastrointestinal Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Cholelithiasis 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Cholelithiasis Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
USGI Medical, Inc. 31
Clinical Trial Overview of USGI Medical, Inc. 31
Catalysis, S.L. 32
Clinical Trial Overview of Catalysis, S.L. 32
Alternova A/S 33
Clinical Trial Overview of Alternova A/S 33
Clinical Trial Overview of Top Institutes / Government 34
University of California, San Diego 34
Clinical Trial Overview of University of California, San Diego 34
Islamic Azad University of Tabriz 35
Clinical Trial Overview of Islamic Azad University of Tabriz 35
Mansoura University 36
Clinical Trial Overview of Mansoura University 36
G. Hatzikosta General Hospital 37
Clinical Trial Overview of G. Hatzikosta General Hospital 37
Massachusetts General Hospital 38
Clinical Trial Overview of Massachusetts General Hospital 38
University of California, San Francisco 39
Clinical Trial Overview of University of California, San Francisco 39
Universidad Juarez Durango 40
Clinical Trial Overview of Universidad Juarez Durango 40
Hospital Son Llatzer 41
Clinical Trial Overview of Hospital Son Llatzer 41
Kuopio University Hospital 42
Clinical Trial Overview of Kuopio University Hospital 42
University of Missouri 43
Clinical Trial Overview of University of Missouri 43
Five Key Clinical Profiles 44
Appendix 58
Abbreviations 58
Definitions 58
Research Methodology 59
Secondary Research 59
About GlobalData 60
Contact Us 60
Disclaimer 60
Source 61

List of Tables
Cholelithiasis Therapeutics, Global, Clinical Trials by Region, 2015* 7
Cholelithiasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Cholelithiasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Cholelithiasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Cholelithiasis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Cholelithiasis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Cholelithiasis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Cholelithiasis Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Cholelithiasis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Cholelithiasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Cholelithiasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Cholelithiasis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Cholelithiasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Cholelithiasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Cholelithiasis Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Cholelithiasis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Cholelithiasis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Cholelithiasis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Cholelithiasis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25
Cholelithiasis Therapeutics, Global, Terminated Clinical Trials, 2015* 25
Cholelithiasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Cholelithiasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27
Cholelithiasis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Cholelithiasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Cholelithiasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by USGI Medical, Inc., 2015* 31
Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Catalysis, S.L., 2015* 32
Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Alternova A/S, 2015* 33
Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2015* 34
Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Islamic Azad University of Tabriz, 2015* 35
Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mansoura University, 2015* 36
Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by G. Hatzikosta General Hospital, 2015* 37
Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2015* 38
Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2015* 39
Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Universidad Juarez Durango, 2015* 40
Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Son Llatzer, 2015* 41
Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Kuopio University Hospital, 2015* 42
Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Missouri, 2015* 43

List of Figures
Cholelithiasis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Cholelithiasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Cholelithiasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Cholelithiasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Cholelithiasis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Cholelithiasis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Cholelithiasis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Proportion of Cholelithiasis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Cholelithiasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Cholelithiasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Cholelithiasis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Cholelithiasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Cholelithiasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Cholelithiasis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Cholelithiasis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Cholelithiasis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Cholelithiasis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Cholelithiasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Cholelithiasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27
Cholelithiasis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Cholelithiasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Cholelithiasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
GlobalData Methodology 59

【レポートのキーワード】

胆石症(Cholelithiasis)、治験、臨床試験、治験、治療薬

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 胆石症(Cholelithiasis):世界の治験レビュー(2015年上半期版)(Cholelithiasis Global Clinical Trials Review, H1, 2015)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆